Inhalers for asthma patients produce significant amounts of greenhouse gases, say S’pore scientists

Each patient using inhalers with propellants in 2023 produced 140kg of CO2 emissions over a year. Read more at ...
New Atlas

First oral GLP-1 cuts cardiovascular risk by 14% – and it's now FDA-approved

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...